Notes
2013 US dollars
Reference
Magnuson EA, et al. Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF-TIMI 48 trial. American Heart Journal 170: 1140-50, No. 6, Dec 2015. Available from: URL: http://doi.org/10.1016/j.ahj.2015.09.011
Rights and permissions
About this article
Cite this article
Edoxaban cost effective for prevention of stroke. PharmacoEcon Outcomes News 744, 14 (2016). https://doi.org/10.1007/s40274-016-2718-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2718-9